By Mill Chart
Last update: Oct 21, 2024
Groth investors are looking for stocks showing high revenue and EPS growth. We will have a look here to see if DOXIMITY INC-CLASS A (NYSE:DOCS) is suited for growth investing, while it is forming a base and may be ready to breakout. Investors should of course do their own research, but we spotted DOXIMITY INC-CLASS A showing up in our growth with base formation screen, so it may be worth spending some more time on it.
Every stock receives a Growth Rating from ChartMill, ranging from 0 to 10. This rating assesses various growth aspects, including historical and projected EPS and revenue growth. NYSE:DOCS boasts a 8 out of 10:
ChartMill utilizes a Health Rating to assess stocks, scoring them on a scale of 0 to 10. This rating takes into account a variety of liquidity and solvency ratios, both in absolute terms and in comparison to industry peers. NYSE:DOCS has earned a 9 out of 10:
ChartMill assigns a proprietary Profitability Rating to each stock. The score is computed by evaluating various profitability ratios and margins and ranges from 0 to 10. NYSE:DOCS was assigned a score of 9 for profitability:
Next to the Technical Rating, the Setup Rating of a stock determines to which extend the stock is consolidating. This score also ranges from 0 to 10 and is updated daily. The setup score evaluates various short term technical indicators. For NYSE:DOCS this score is currently 9:
Besides having an excellent technical rating, DOCS also presents a decent setup pattern. Prices have been consolidating lately. There is a resistance zone just above the current price starting at 43.84. Right above this resistance zone may be a good entry point. There is a support zone below the current price at 43.48, a Stop Loss order could be placed below this zone. Another positive sign is the recent Pocket Pivot signal.
Our Strong Growth screener lists more Strong Growth stocks and is updated daily.
Our latest full fundamental report of DOCS contains the most current fundamental analsysis.
For an up to date full technical analysis you can check the technical report of DOCS
This article should in no way be interpreted as advice. The article is based on the observed metrics at the time of writing, but you should always make your own analysis and trade or invest at your own responsibility.
53.21
+0.43 (+0.81%)
Find more stocks in the Stock Screener
NYSE:DOCS is scoring great on several growth aspects while it also shows decent health and profitability. At the same time it remains remains attractively priced.